Proud of our nomination for the Flowsparks Award 2026

We have been selected as one of 12 finalists from a large number of entries. This is a recognition that we at Vinçotte – a Kiwa Company are extremely proud of.

We need your help to win this nomination! Every vote brings us closer to the award. We would therefore like to invite you to help us. You can vote via the Flowsparks website.

Innovation in Nuclear Medicine

Radionuclide therapy is a rapidly growing and complex field within the medical world. Combining diagnostics and therapy requires specific expertise and continuous training. Our award-winning e-learning programme has been developed to support medical professionals, from nuclear specialists and authorised representatives to medical imaging specialists, in their professional development in an accessible and high-quality manner.

Why this training course makes a difference

The nomination is not only recognition for the technology behind the e-learning, but above all for the depth of content and practical added value:

• Accredited quality: The three-hour training course is recognised by the FANC as continuing professional development.

• Full spectrum: From the basic principles and radiation protection, the course of therapy and metabolic chambers to therapies in clinical routine (I-131, Lu-177, etc.) and innovative alpha nuclides (such as Ac-225).

• Flexible learning: Professionals can view the e-learning course wherever and whenever it suits them, without compromising on the depth of the subject matter.

Teamwork

We could not have achieved this nomination without the input of our Vinçotte Controlatom experts and the feedback from the students who use our e-learning course every day to take patient care to the next level.

We are eagerly looking forward to the Flowsparks Awards ceremony in Amersfoort on 12 March 2026.

Would you like to know more about our nominated e-learning course and our digital offering?

Visit the Vinçotte Academy website for a full overview of our trainings.